“…Between the two groups, HbA1c reduction is significant (P ≤ 0.01). The result was similar to those reported by other studies like Chatterjee, [15] Charbonnel et al, [16] Filozof and Gautier, [19] Muthukrishnan et al, [20] Kesavadev et al, [21] and Sahai et al [18] The current study used CEA, the cost comprised the direct costs involved in buying the drugs only . there was no adverse drug effect reported in any group, so additional cost for management of adverse effect is not included.…”